All In Biotech

Drug Trial Radar · NCT04378868

Role of Delay and Antibiotics on Perforation Rate While Waiting Appendectomy

Role of Delay and Antibiotics on PERForation Rate While Waiting appendECTomy - Randomized Non-inferiority Trial

Last checked: Nov 19, 2026Latest source record: Jul 11, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,800 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,800

Actual

Start

May 18, 2020

Primary completion

Jan 23, 2023

Study completion Feb 23, 2023

Sponsor

Lead sponsor
Helsinki University Central HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 7, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the effects of preoperative delay and antibiotics on perforation rate of appendix while waiting surgery for acute appendicitis. Patients with diagnosed acute appendicitis are randomized into two urgency groups: surgery within 8 hours or surgery within 24 hours. In addition, patients are randomized to either receive antibiotics while waiting or waiting without antibiotics.

Conditions

  • Appendicitis

Interventions

  • Antibiotics, cefuroxime and metronidazoleDrug

    Patient receives antibiotics while waiting appendectomy

  • No antibioticsDrug

    No antibiotics are given while waiting surgery.

  • urgent scheduleOther

    Patients can wait up to 8 hours for surgery.

  • less urgent scheduleOther

    Patients can wait up to 24 hours for surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complicated appendicitisTime frame: during surgery

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • HUS, Jorvi Hospital

    Espoo, Finland

  • HUS, Meilahti Hospital

    Helsinki, Finland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.